OpiCalc Logo

OpiCalc

989 Clinical Tools

Logo
OpiCalc
ABC-AF Bleeding ScoreABC-AF Stroke ScoreABCD2 ScoreADD-RSAortic Valve Calcium ScoreAPPLE ScoreASCVD (Pooled Cohort)AVA (Continuity Equation)BAG-AHF ScoreBiplane Simpson EFBlood Pressure PercentilesBrugada Criteria (VT vs SVT)Cardiac Output IndexCHA2DS2-VAScCHADS2Cornell Voltage CriteriaCRUSADE Bleeding ScoreDAPT ScoreDASIDuke Treadmill ScoreE/A RatioEDACS ScoreEHMRGEHRA ScoreEmbolic Risk ScoreEROA (PISA Method)FFR (Fractional Flow Reserve)Fick Cardiac OutputFramingham 10-Year RiskFriedewald LDL EquationGorlin EquationGRACE ScoreGupta MICA (NSQIP)GWTG-HF ScoreH2FPEF ScoreHakki FormulaHAS-BLEDHEART PathwayHEART ScoreHEMORR2HAGEShs-Troponin 0h/1h ESC AlgorithmiFRINTERCHEST ScoreKillip ClassificationLee's RCRILV Mass IndexLV Stroke Work IndexMAGGIC Risk ScoreMAP CalculatorMartin/Hopkins LDLModified Duke CriteriaModified Sgarbossa CriteriaMVA (Pressure Half-Time)Non-HDL CholesterolNT-proBNP Age-Adjusted ThresholdsORBIT ScoreOttawa Heart Failure RiskPulse PressurePVR CalculatorPVR IndexQRISK3QTc (Bazett)QTc (Fridericia)REVEAL 2.0 ScoreREVEAL Lite 2Reynolds Risk ScoreROSIRVSP CalculatorSchwartz Score (LQTS)SCORE2Seattle Heart Failure Model (SHFM)Sgarbossa CriteriaShock IndexSokolow-Lyon VoltageStroke Volume IndexSVR CalculatorSYNTAX ScoreSYNTAX Score IITAPSETeichholz FormulaTIMI (STEMI)TIMI (UA/NSTEMI)Troponin Delta CalculatorValvular GradientsVancouver Chest Pain RuleVereckei AlgorithmWATCHDM ScoreWilkins ScoreWood Units Calculator
OpiCalc Logo

OpiCalc

Open-access clinical infrastructure. Built to the standard every clinician deserves — fast, private, and free.

Zero data stored
Always free
Our mission & transparency

Get in Touch

Tool request, clinical feedback, or partnership inquiry — we read everything.

WhatsApp feedback
Email us
Partnership inquiry

© 2026 OpiCalc • Calculated Care

ProtocolsAboutPrivacyTerms

Biplane Simpson EF

Biplane Simpson EF: LV ejection fraction from apical 2- and 4-chamber disk summation method.

Formula

EF = (avg EDV − avg ESV) / avg EDV × 100%

Guidelines & Evidence

Clinical Details

Section 1

When to Use

When to Use

Primary LV systolic function assessment on transthoracic echo
HF diagnosis and severity stratification
Post-MI LV function assessment
Cardiotoxicity monitoring (chemotherapy, HER2 inhibitors)
Serial monitoring in LVAD candidates
More accurate than M-mode (Teichholz) in most patients

Key Advantages

Less dependent on geometric assumptions vs. M-mode
Validated against cardiac MRI gold standard
Incorporates regional function variations
Recommended by ESC/AHA guidelines as primary measurement
Reproducible across operators with good image quality
Section 2

Formula & Logic

Calculation Methodology

Requires apical 2-chamber and 4-chamber views
Tracings of LV endocardium in diastole and systole
LV volume = Σ cylinder volumes stacked base-to-apex
Formula: EF = (EDV − ESV) / EDV × 100%
Biplane method averages 2- and 4-chamber calculations

LV EF Classification

LVEF (%)ClassificationClinical Correlate
>50NormalNo LV dysfunction
41–49Mildly ReducedHFmrEF (newer category)
31–40Moderately ReducedHFrEF (may be symptomatic)
≤30Severely ReducedHFrEF; high risk; LVAD/transplant candidate
Section 3

Pearls/Pitfalls

Technical Considerations

Image quality critical; foreshortened views → artifactually low EF
Apical thrombus can be included accidentally; visual assessment essential
Paradoxical septal motion (post-cardiac surgery) affects accuracy
Normal EF does NOT exclude diastolic dysfunction or HFpEF
Serial EF drop >5% during chemotherapy warrants intervention

Clinical Pitfalls

Foreshortened apical 4-chamber overestimates EF
Excessive papillary muscle inclusion underestimates volumes
Young athlete physiology (eccentric LV hypertrophy) may lower EF slightly
Tachycardia / arrhythmia reduces reproducibility; average multiple beats
Section 4

Next Steps

LVEF >50% (Normal)

Normal LV systolic function; reassess if new symptoms
Assess diastolic function if dyspnoea present
Standard follow-up based on clinical indication

LVEF 41–49% (Mildly Reduced / HFmrEF)

Offers risk for HF progression; optimize BP/HR
Consider SGLT2i therapy per recent guidelines
Annual echo surveillance
Identify and treat reversible causes

LVEF 31–40% (Moderately Reduced)

HFrEF diagnosis; initiate quadruple therapy: ACEi/ARB, β-blocker, MRA, SGLT2i
ICD evaluation if EF expected to remain ≤35% after 40 days therapy
CRT consideration if QRS ≥120 ms + symptoms
3–6 month repeat echo after therapy initiation

LVEF ≤30% (Severely Reduced)

High-risk HFrEF; aggressive pharmacotherapy + device therapy
ICD indicated for primary prevention if stable >40 days
Urgent cardiology consultation; evaluate LVAD/transplant candidacy
Monthly clinical monitoring; repeat echo every 3–6 months

Complementary Calculators

TAPSE (RV Systolic Function)
LV Mass Index
AVA (Continuity Equation)
EROA (PISA Method)
MVA (Pressure Half-Time)
Section 5

Evidence Appraisal

Validation

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Lang RM et al. • J Am Soc Echocardiogr.. 2015;e1-39. The landmark guideline for EF quantification.

Section 6

Literature

Development

Biplane Simpson method has become the standard echocardiographic LV function assessment since the 1990s. Formalized in ASE guideline documents; now universal in echo labs worldwide.

Last Comprehensive Review: 2026

Related Cardiovascular Tools

ABC-AF Bleeding Score
ABC-AF Stroke Score
ABCD2 Score
ADD-RS
Aortic Valve Calcium Score
APPLE Score
ASCVD
AVA
BAG-AHF Score
Blood Pressure Percentiles
Have feedback about this calculator?Let us know.